Searched for: person:muisee01
in-biosketch:true
Pulmonary and Radiographic Findings in Pediatric Type 1 Laryngeal Cleft
Francisco, Sarah; Muise, Eleanor; D'Anna, Rachel; Dahlberg, Suzanne; Rajeev, Devika; Visner, Gary; Watters, Karen; Rosen, Rachel; Rahbar, Reza; Simoneau, Tregony
OBJECTIVE:Laryngeal clefts are congenital malformations that can result in chronic microaspiration and subsequent lung disease. Type 1 laryngeal clefts can result in subtle presentation and whether or not to repair them remains controversial. In this retrospective cohort study, we describe the pulmonary symptoms and radiographic findings in children before and after type 1 laryngeal cleft repair. STUDY DESIGN/METHODS:Twenty-year single institution retrospective cohort study. METHODS:-laser repair between August 2003 and August 2022. Data collected included history of respiratory illness, pulmonary symptoms, medications pre-repair, and radiographic findings pre- and post-repair. Pre- and post-repair chest x-ray (CXR) findings were compared. RESULTS:325 pediatric patients (200 male and 125 female; median age at repair 2.6 years) required surgical repair between 2003 and 2022. Nearly all (99%) patients presented with respiratory symptoms, nearly half (44%) had a history of pneumonia, and 71% were prescribed at least one pulmonary medication. Median age at laryngeal cleft repair was higher in patients with a history of pneumonia (3.0 years, range 0.5-16.4) compared to patients without pneumonia (2.3 years, range 0.3-16.5), p < 0.001. Abnormal CXR findings were common (80%), with atelectasis (56%) and bronchial wall thickening (59%) being most prevalent. Atelectasis and bronchial wall thickening were significantly less frequent in the post-repair CXRs. CONCLUSIONS:Pulmonary symptoms and abnormal CXR findings are common in patients with type 1 laryngeal cleft, and those who do not respond properly to medical management should be considered for endoscopic repair.
PMID: 40227884
ISSN: 1531-4995
CID: 5827442
Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth
Muise, Eleanor D; Gordon, Rachel; Steiding, Jacqueline; Sullivan, Keri; Sheils, Catherine A; Casey, Alicia M
BACKGROUND AND OBJECTIVES/OBJECTIVE:The vaping epidemic is a public health crisis worldwide. E-cigarette, or vaping product, use-associated lung injury (EVALI) was recognised in the summer of 2019 and resulted in more than 2800 hospitalizations and 60 deaths per the Centres for Disease Control and Prevention (CDC). Vaping refers to the use of E-cigarettes, which are electronic nicotine delivery systems (ENDS) and mimic smoking without combustion. Over 40 million people in the United States vape, of which youth and young adults represent over half. We describe the evaluation and pulmonary complications in a large cohort of adolescents and young adults referred to a Pulmonary Complications of Vaping Clinic. METHODS:Youth ages 10-35 with a vaping history and respiratory symptoms underwent a comprehensive diagnostic evaluation. All patients were counselled for vaping cessation. Patients who met criteria for EVALI or probable EVALI with concurrent infection were reported to the Department of Health. RESULTS:One hundred and thirty patients were referred, and 103 patients underwent comprehensive diagnostic evaluation. Eighty-four percent of patients reported vaping both marijuana and nicotine products. Forty-six percent of patients were diagnosed with EVALI or probable EVALI. CONCLUSIONS:The evolving vaping epidemic demonstrates a need for subject matter expertise in the evaluation and diagnosis of youth with vaping-related lung injury, including EVALI. We report a higher number of youth who met criteria for EVALI with the implementation of a standardised vaping questionnaire and evaluation inclusive of outpatients.
PMID: 40135485
ISSN: 1440-1843
CID: 5815632
New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR-related metabolic syndrome
Choudhary, Saroj; Muise, Eleanor D; Hammouda, Soumia; Goetz, Danielle; Giusti, Robert
BACKGROUND:New York (NY) State implemented a new cystic fibrosis (CF) newborn screen (NBS) algorithm in December 2017 with improvement in positive predictive value and unanticipated increased identification of infants with cystic fibrosis transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS). Repeat sweat testing is recommended in infants with CRMS. During the COVID-19 pandemic infants with CRMS were lost to follow up. With this quality improvement (QI) initiative, we aimed to perform repeat sweat testing in 25% of infants lost to follow up. We also describe consensus recommendations for CRMS from the NY CF NBS Consortium. METHODS:Our QI team identified the primary drivers contributing to absent follow up, outreached to families, and created a questionnaire to evaluate parental understanding of CRMS using QI-based strategies. RESULTS:Of 350 infants diagnosed with CRMS during the study period, 179 (51.1%) infants were lost to follow up. A total of 31 (17.3%) were scheduled for repeat sweat tests and followed up at CF Centers. Families reported high satisfaction with the CRMS knowledge questionnaire. CONCLUSIONS:With this QI-based approach, we effectively recaptured infants with CRMS previously lost to follow up during the COVID-19 pandemic. Ongoing concerns about infection risk and lack of understanding on the part of families and pediatricians likely contributed to patients with CRMS lost to follow up. Consensus recommendations for CRMS include annual visits with repeat sweat testing until 2-6 years of age and education for adolescents about clinical and reproductive implications of CRMS.
PMID: 38990093
ISSN: 1099-0496
CID: 5711172
Pediatric Lung Transplantation for Pulmonary Vascular Diseases: Recent Advances and Challenges
Midyat, Levent; Muise, Eleanor D; Visner, Gary A
Pediatric lung transplantation for pulmonary vascular diseases has seen notable advancements and trends. Medical therapies, surgical options, and bridging techniques like extracorporeal membrane oxygenation and different forms of transplants have expanded treatment possibilities. Current challenges include ensuring patient adherence to post-transplant therapies, addressing complications like primary graft dysfunction and rejection, and conducting further research in less common conditions like pulmonary veno-occlusive disease and pulmonary vein stenosis. In this review article, the authors will explore the advancements, emerging trends, and persistent challenges in pediatric lung transplantation for pulmonary vascular diseases.
PMID: 39069336
ISSN: 1557-8216
CID: 5731212
Outcomes of surgical treatment of tracheobronchomalacia in children
Mukharesh, Lana; Krone, Katie A; Hamilton, Thomas E; Shieh, Hester F; Smithers, Charles J; Winthrop, Zachary A; Muise, Eleanor D; Jennings, Russell W; Mohammed, Somala; Demehri, Farokh R; Zendejas, Benjamin; Visner, Gary A
BACKGROUND:Tracheobronchomalacia (TBM) is characterized by excessive dynamic airway collapse. Severe TBM can be associated with substantial morbidity. Children with secondary TBM associated with esophageal atresia/tracheoesophageal fistula (EA/TEF) and vascular-related airway compression (VRAC) demonstrate clinical improvement following airway pexy surgery. It is unclear if children with severe primary TBM, without secondary etiologies (EA/TEF, vascular ring, intrinsic pulmonary pathology, or complex cardiac disease) demonstrate clinical improvement following airway pexy surgery. MATERIALS AND METHODS/METHODS:The study cohort consisted of 73 children with severe primary TBM who underwent airway pexy surgery between 2013 and 2020 at Boston Children's Hospital. Pre- and postoperative symptoms as well as bronchoscopic findings were compared with Fisher exact test for categorical data and Student's t-test for continuous data. RESULTS:Statistically significant improvements in clinical symptoms were observed, including cough, noisy breathing, prolonged respiratory infections, pneumonias, exercise intolerance, cyanotic spells, brief resolved unexplained events (BRUE), and noninvasive positive pressure ventilation (NIPPV) dependence. No significant differences were seen regarding oxygen dependence, ventilator dependence, or respiratory distress requiring NIPPV. Comparison of pre- and postoperative dynamic bronchoscopy findings revealed statistically significant improvement in the percent of airway collapse in all anatomic locations except at the level of the upper trachea (usually not malacic). Despite some initial improvements, 21 (29%) patients remained symptomatic and underwent additional airway pexies with improvement in symptoms. CONCLUSION/CONCLUSIONS:Airway pexy surgery resulted in significant improvement in clinical symptoms and bronchoscopic findings for children with severe primary TBM; however, future prospective and long-term studies are needed to confirm this benefit.
PMID: 38629381
ISSN: 1099-0496
CID: 5731662
Diastolic dysfunction manifesting as acute plastic bronchitis after Warden procedure [Case Report]
Pasternack, Daniel M; Martinez, Michael J; McKinstry, Jacqueline; Singh, Rakesh; Saharan, Sunil; Muise, Eleanor D; Mosca, Ralph; Kumar, T K Susheel
PMCID:11184659
PMID: 38899069
ISSN: 2666-2507
CID: 5689522
Meconium ileus and pancreatic sufficiency with D1152H mutation: A case report and review of the literature [Case Report]
Lang, Emma; Kiernan, Bridget; Muise, Eleanor D; Giusti, Robert
Meconium ileus (MI) is one presenting manifestation of Cystic Fibrosis (CF), classically associated with class I-III CF transmembrane conductance regulator (CFTR) mutations and pancreatic insufficiency (PI). D1152H is a class IV mutation that corresponds with a milder CF phenotype and pancreatic sufficiency (PS). We present the case of an infant with G542X/D1152H mutations and MI who required surgical intervention with small bowel resection. The sweat testing was normal, and this child presently remains PS, however at age 5 continues to experience short gut syndrome and failure to thrive. Eight cases were identified in the CF Registry and seven cases in the literature describing patients with D1152H and echogenic bowel (EB) or MI. Our case highlights the importance of CFTR gene sequencing in infants with EB or MI and sweat testing not suggestive of CF. It is our practice to perform full CFTR gene sequencing for infants who present with MI, recognizing protocols for newborn screening across the United States vary. Increased awareness of D1152H association with PS may also well inform both prenatal and postnatal genetic counseling.
PMID: 37423798
ISSN: 1873-5010
CID: 5537332
Implementing Remote Patient Monitoring of Physical Activity in Clinical Practice
McCarthy, Margaret; Jevotovsky, David; Mann, Devin; Veerubhotla, Akhila; Muise, Eleanor; Whiteson, Jonathan; Rizzo, John Ross
PURPOSE/OBJECTIVE:Remote patient monitoring (RPM) is a tool for patients to share data collected outside of office visits. RPM uses technology and the digital transmission of data to inform clinician decision-making in patient care. Using RPM to track routine physical activity is feasible to operationalize, given contemporary consumer-grade devices that can sync to the electronic health record. Objective monitoring through RPM can be more reliable than patient self-reporting for physical activity. DESIGN AND METHODS/METHODS:This article reports on four pilot studies that highlight the utility and practicality of RPM for physical activity monitoring in outpatient clinical care. Settings include endocrinology, cardiology, neurology, and pulmonology settings. RESULTS:The four pilot use cases discussed demonstrate how RPM is utilized to monitor physical activity, a shift that has broad implications for prediction, prevention, diagnosis, and management of chronic disease and rehabilitation progress. CLINICAL RELEVANCE/CONCLUSIONS:If RPM for physical activity is to be expanded, it will be important to consider that certain populations may face challenges when accessing digital health services. CONCLUSION/CONCLUSIONS:RPM technology provides an opportunity for clinicians to obtain objective feedback for monitoring progress of patients in rehabilitation settings. Nurses working in rehabilitation settings may need to provide additional patient education and support to improve uptake.
PMID: 37723623
ISSN: 2048-7940
CID: 5591172
Implementing Remote Patient Monitoring of Physical Activity in Clinical Practice
Mccarthy, Margaret; Jevotovsky, David; Mann, Devin; Veerubhotla, Akhila; Muise, Eleanor; Whiteson, Jonathan; Rizzo, John Ross
ISI:001100769700008
ISSN: 0278-4807
CID: 5591122
Vaping and e-cigarette use. Mysterious lung manifestations and an epidemic
Casey, Alicia M; Muise, Eleanor D; Crotty Alexander, Laura E
Electronic (e)-cigarette use and the practice of vaping has rapidly expanded both in adult smokers and previously nicotine naïve youths. Research has focused on harm reduction in adults using e-cigarettes to stop or reduce traditional cigarette use, but the short and long-term safety of these products has not been established. Vaping has more recently been associated with a growing list of pulmonary complications with the most urgent being the e-cigarette or vaping product use-associated lung injury (EVALI) epidemic. This review details the inhalant toxicology of vaping products, the described lung diseases associated with vaping with a focus on EVALI, and the predicted long-term consequences of e-cigarette use, including increased asthma severity.
PMCID:7755270
PMID: 33186869
ISSN: 1879-0372
CID: 4793522